PT2576624T - Dímero do g-csf humano recombinante e sua utilização para o tratamento de doenças neurológicas - Google Patents
Dímero do g-csf humano recombinante e sua utilização para o tratamento de doenças neurológicasInfo
- Publication number
- PT2576624T PT2576624T PT117860916T PT11786091T PT2576624T PT 2576624 T PT2576624 T PT 2576624T PT 117860916 T PT117860916 T PT 117860916T PT 11786091 T PT11786091 T PT 11786091T PT 2576624 T PT2576624 T PT 2576624T
- Authority
- PT
- Portugal
- Prior art keywords
- treatment
- recombinant human
- neurological diseases
- csf dimer
- csf
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Vascular Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101816235A CN102260343A (zh) | 2010-05-25 | 2010-05-25 | 重组人g-csf二聚体在治疗神经损伤疾病中的用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2576624T true PT2576624T (pt) | 2016-10-31 |
Family
ID=45003325
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT117860916T PT2576624T (pt) | 2010-05-25 | 2011-05-25 | Dímero do g-csf humano recombinante e sua utilização para o tratamento de doenças neurológicas |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US8557546B2 (pt) |
| EP (2) | EP2576624B1 (pt) |
| JP (1) | JP6114186B2 (pt) |
| CN (3) | CN102260343A (pt) |
| AU (1) | AU2011257734B2 (pt) |
| CA (1) | CA2800688C (pt) |
| DK (2) | DK2576624T3 (pt) |
| ES (2) | ES2750730T3 (pt) |
| FI (1) | FIC20240027I1 (pt) |
| HU (1) | HUE031872T2 (pt) |
| PL (1) | PL2576624T3 (pt) |
| PT (1) | PT2576624T (pt) |
| WO (1) | WO2011147319A1 (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8637637B2 (en) * | 2010-01-12 | 2014-01-28 | Bill Nai-Chau Sun | Fc fusion proteins of human growth hormone |
| CN102260343A (zh) | 2010-05-25 | 2011-11-30 | 健能隆医药技术（上海）有限公司 | 重组人g-csf二聚体在治疗神经损伤疾病中的用途 |
| CN102380090A (zh) * | 2010-08-31 | 2012-03-21 | 健能隆医药技术（上海）有限公司 | G-csf二聚体在治疗嗜中性粒细胞减少症中的应用 |
| AU2012289433B2 (en) * | 2011-07-25 | 2017-07-27 | Evive Biotechnology (Shanghai) Ltd | Use of G-CSF dimer in preparation of medicament for treatment of neurodegenerative diseases |
| EP2742064B1 (en) | 2011-08-09 | 2016-07-27 | UAB Profarma | Derivatives of recombinant proteins, homo-multimers of granulocyte colony-stimulating factor and method of preparation thereof |
| US9359374B2 (en) * | 2012-06-13 | 2016-06-07 | Apotex Pharmachem Inc. | Polymorphic forms of rifaximin |
| LT6161B (lt) * | 2013-09-27 | 2015-06-25 | Uab Profarma | Granuliocitų kolonijas stimuliuojančio faktoriaus sulieti baltymai su kitais augimo faktoriais, optimaliai su kamieninių ląstelių faktoriumi, ir jų gavimo būdas |
| CN113480667B (zh) * | 2021-08-17 | 2023-03-28 | 长春萤火虫生物科技有限公司 | 一种人粒细胞集落刺激因子突变体重组融合蛋白及其制备方法和应用 |
| WO2024037633A2 (en) | 2022-08-19 | 2024-02-22 | Evive Biotechnology (Shanghai) Ltd | Formulations comprising g-csf and uses thereof |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3954004B2 (ja) | 1991-12-26 | 2007-08-08 | 中外製薬株式会社 | 脳機能障害による疾患の予防・治療薬 |
| CA2212006A1 (en) | 1995-02-03 | 1996-08-08 | G.D. Searle & Co. | Novel c-mpl ligands |
| US6551799B2 (en) | 1999-12-07 | 2003-04-22 | Genentech, Inc. | Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| US6660843B1 (en) | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
| US6331613B1 (en) | 1998-10-26 | 2001-12-18 | Ludwig Institue For Cancer Research | Isolated nucleic acid molecules which encode T cell inducible factors (TIFS), the proteins encoded, and uses thereof |
| US6274710B1 (en) | 1998-10-26 | 2001-08-14 | Ludwig Institute For Cancer Research | Antibodies which specifically bind T Cell inducible factors (TIFs) |
| US7307161B1 (en) | 1999-04-28 | 2007-12-11 | Genetics Institute, Llc | Human Gil-19/AE289 polynucleotides |
| US7754855B1 (en) * | 1999-07-13 | 2010-07-13 | Bolder Biotechnology, Inc. | Immunoglobulin fusion proteins |
| GB0024442D0 (en) | 2000-10-05 | 2000-11-22 | Isis Innovation | Genetic factors affecting the outcome of viral infections |
| WO2002036626A1 (en) * | 2000-11-02 | 2002-05-10 | Maxygen Aps | Single-chain multimeric polypeptides |
| US20020142964A1 (en) | 2000-11-02 | 2002-10-03 | Nissen Torben Lauesgaard | Single-chain polypeptides |
| US6900292B2 (en) * | 2001-08-17 | 2005-05-31 | Lee-Hwei K. Sun | Fc fusion proteins of human erythropoietin with increased biological activities |
| US6797493B2 (en) | 2001-10-01 | 2004-09-28 | Lee-Hwei K. Sun | Fc fusion proteins of human granulocyte colony-stimulating factor with increased biological activities |
| EP1572936A2 (en) * | 2002-03-05 | 2005-09-14 | Eli Lilly And Company | Heterologous g-csf fusion proteins |
| US7785601B2 (en) | 2002-12-31 | 2010-08-31 | Sygnis Bioscience Gmbh & Co. Kg | Methods of treating neurological conditions with hematopoietic growth factors |
| ATE544463T1 (de) | 2004-11-05 | 2012-02-15 | Univ Northwestern | Verwendung von scf und g-scf bei der behandlung von hirnischämie und neurologischen störungen |
| CN100515491C (zh) | 2005-01-04 | 2009-07-22 | 健能隆医药技术（上海）有限公司 | 白介素-22的医药用途 |
| US7625564B2 (en) | 2006-01-27 | 2009-12-01 | Novagen Holding Corporation | Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
| WO2008137571A1 (en) | 2007-05-01 | 2008-11-13 | Florida Atlantic University | Methods of treating neurodegenerative diseases |
| WO2008147534A1 (en) | 2007-05-22 | 2008-12-04 | Maxygen Holdings Ltd. | Method for the treatment of neutropenia by administration of a multi-pegylated granulocyte colony stimulating factor (g-csf) variant |
| EP3173484B1 (en) | 2007-05-30 | 2018-09-26 | Postech Academy-Industry- Foundation | Immunoglobulin fusion proteins |
| US20110182848A1 (en) | 2007-08-03 | 2011-07-28 | Asterion Limited | Granulocyte colony stimulating factor |
| CN101361968B (zh) | 2007-08-06 | 2011-08-03 | 健能隆医药技术（上海）有限公司 | 白介素-22在治疗脂肪肝中的应用 |
| CA2705007A1 (en) | 2007-11-07 | 2009-05-14 | Genentech, Inc. | Compositions and methods for treatment of microbial disorders |
| ES2654387T3 (es) | 2008-07-23 | 2018-02-13 | Ambrx, Inc. | Polipéptidos G-CSF bovinos modificados y sus usos |
| CA2788096A1 (en) | 2010-01-13 | 2011-07-21 | Amgen Inc. | Il-22-fc and hepcidin activity |
| LT2010012A (lt) | 2010-02-10 | 2011-08-25 | Uab Profarma, , | Granulocitus stimuliuojančio baltymo linijiniai oligomerai su prailginta in vivo gyvavimo trukme |
| LT2010013A (lt) | 2010-02-10 | 2011-08-25 | Uab Profarma, , | Biologiškai aktyvių granulocitų kolonijas stimuliuojančio faktoriaus darinių išskyrimo ir gryninimo būdas |
| CN102260343A (zh) | 2010-05-25 | 2011-11-30 | 健能隆医药技术（上海）有限公司 | 重组人g-csf二聚体在治疗神经损伤疾病中的用途 |
| CN102380090A (zh) | 2010-08-31 | 2012-03-21 | 健能隆医药技术（上海）有限公司 | G-csf二聚体在治疗嗜中性粒细胞减少症中的应用 |
| AU2012289433B2 (en) | 2011-07-25 | 2017-07-27 | Evive Biotechnology (Shanghai) Ltd | Use of G-CSF dimer in preparation of medicament for treatment of neurodegenerative diseases |
-
2010
- 2010-05-25 CN CN2010101816235A patent/CN102260343A/zh active Pending
-
2011
- 2011-05-23 US US13/114,035 patent/US8557546B2/en active Active
- 2011-05-25 JP JP2013511527A patent/JP6114186B2/ja active Active
- 2011-05-25 AU AU2011257734A patent/AU2011257734B2/en active Active
- 2011-05-25 EP EP11786091.6A patent/EP2576624B1/en active Active
- 2011-05-25 ES ES16185991T patent/ES2750730T3/es active Active
- 2011-05-25 DK DK11786091.6T patent/DK2576624T3/en active
- 2011-05-25 CA CA2800688A patent/CA2800688C/en active Active
- 2011-05-25 CN CN201180025773.XA patent/CN102906120B/zh active Active
- 2011-05-25 ES ES11786091.6T patent/ES2611151T3/es active Active
- 2011-05-25 HU HUE11786091A patent/HUE031872T2/en unknown
- 2011-05-25 DK DK16185991T patent/DK3121198T3/da active
- 2011-05-25 CN CN201510112334.2A patent/CN104710535B/zh active Active
- 2011-05-25 PL PL11786091T patent/PL2576624T3/pl unknown
- 2011-05-25 EP EP16185991.3A patent/EP3121198B1/en active Active
- 2011-05-25 PT PT117860916T patent/PT2576624T/pt unknown
- 2011-05-25 WO PCT/CN2011/074678 patent/WO2011147319A1/en active Application Filing
-
2013
- 2013-08-30 US US14/014,413 patent/US9273108B2/en active Active
-
2024
- 2024-07-30 FI FIC20240027C patent/FIC20240027I1/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP6114186B2 (ja) | 2017-04-12 |
| EP2576624A1 (en) | 2013-04-10 |
| DK3121198T3 (da) | 2019-10-28 |
| US20110293554A1 (en) | 2011-12-01 |
| CA2800688C (en) | 2018-05-15 |
| PL2576624T3 (pl) | 2017-02-28 |
| WO2011147319A1 (en) | 2011-12-01 |
| CN104710535A (zh) | 2015-06-17 |
| CN102260343A (zh) | 2011-11-30 |
| US8557546B2 (en) | 2013-10-15 |
| CN104710535B (zh) | 2018-10-16 |
| CN102906120B (zh) | 2015-03-04 |
| JP2013530148A (ja) | 2013-07-25 |
| US20140004076A1 (en) | 2014-01-02 |
| DK2576624T3 (en) | 2016-11-14 |
| US9273108B2 (en) | 2016-03-01 |
| EP3121198B1 (en) | 2019-08-14 |
| ES2750730T3 (es) | 2020-03-26 |
| EP3121198A1 (en) | 2017-01-25 |
| AU2011257734A1 (en) | 2012-12-20 |
| CN102906120A (zh) | 2013-01-30 |
| EP2576624A4 (en) | 2013-11-13 |
| ES2611151T3 (es) | 2017-05-05 |
| HUE031872T2 (en) | 2017-08-28 |
| CA2800688A1 (en) | 2011-12-01 |
| EP2576624B1 (en) | 2016-08-31 |
| AU2011257734B2 (en) | 2015-06-11 |
| FIC20240027I1 (fi) | 2024-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2576624T (pt) | Dímero do g-csf humano recombinante e sua utilização para o tratamento de doenças neurológicas | |
| HK1258028A1 (zh) | 人類抗體及其在神經疾病治療中的診斷和治療用途 | |
| HRP20160714T1 (hr) | Sredstva za induciranje apoptoze namijenjena liječenju raka i imunih i autoimunih bolesti | |
| HK1219092A1 (zh) | 用於治療癌症和免疫以及自身免疫性疾病的細胞凋亡誘導劑 | |
| HK1163500A1 (en) | Pharmaceutical composition for the treatment of heart diseases | |
| PH12013500892A1 (en) | Composition for use in the prevention and/or treatment of skin conditions and skin diseases | |
| EP2621499A4 (en) | METHODS OF TREATING ALLERGIC DISEASES | |
| HK1183866A1 (en) | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | |
| EP2621501A4 (en) | POLYCYCLIC HETEROCYCLIC DERIVATIVES AND METHODS FOR THEIR USE IN THE TREATMENT OF VIRAL DISEASES | |
| IL224544B (en) | Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound | |
| EP2528603A4 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PAIN AND OTHER INDICATIONS | |
| HK1184370A1 (zh) | 用於治療疼痛的藥物組合 | |
| EP2612676A4 (en) | USE OF A G-CSF DIMER IN THE TREATMENT OF NEUTROPENIA | |
| EP2616094A4 (en) | TREATMENT OF BRAIN INJURIES THROUGH IMPORTS | |
| EP2624821A4 (en) | POLYTHERAPY FOR THE TREATMENT OF DEPRESSION AND OTHER NON-INFECTIOUS DISEASES | |
| EP2949651A4 (en) | SUBSTITUTED BENZOTHIAZOLES AND THEIR THERAPEUTIC APPLICATIONS FOR THE TREATMENT OF HUMAN DISEASES | |
| EP2709632A4 (en) | COMPOSITIONS AND METHOD FOR THE TREATMENT OF SKIN DISEASES | |
| PT2555790T (pt) | USO TERAPÊUTICO DA PROTEÍNA DE ß MICROGLOBULINA | |
| HK1214771A1 (zh) | 用於治療皮膚病的製劑 | |
| IL204097A0 (en) | Medicine for the treatment of skin cancer |